Analysts' Opinions Are Mixed on These Healthcare Stocks: Beam Therapeutics (BEAM), Cormedix (CRMD) and Applied Therapeutics (APLT)

TipRanksMay 11 09:50

Beam Therapeutics: A Hold Rating Amid Controlled R&D Spending and Upcoming Clinical Milestones

TipRanksMay 10 13:18

Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD), Beam Therapeutics (BEAM) and Mirum Pharmaceuticals (MIRM)

TipRanksMay 9 20:30

Beam Therapeutics Is Maintained at Equal-Weight by Barclays

Beam Therapeutics Is Maintained at Equal-Weight by Barclays

Dow JonesMay 9 02:14

Beam Therapeutics Price Target Cut to $33.00/Share From $42.00 by Barclays

Beam Therapeutics Price Target Cut to $33.00/Share From $42.00 by Barclays

Dow JonesMay 9 02:14

Barclays Maintains Equal-Weight on Beam Therapeutics, Lowers Price Target to $33

Barclays analyst Gena Wang maintains Beam Therapeutics (NASDAQ:BEAM) with a Equal-Weight and lowers the price target from $42 to $33.

BenzingaMay 9 02:03